| Somatostatin |
II-0859/15.10.2007 |
Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA, Belgium |
3.72 |
0.74 |
4.46 |
7% |
0.26 |
3.98 |
0.8 |
4.78 |
20% |
0.74 |
4.72 |
0.94 |
5.66 |
|
НСР-5738/26.02.2015. |
12.03.2015 |
12.03.2015 |
Неактивен |
3635 |
| Somatostatin |
II-0859/15.10.2007 |
Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA, Belgium |
3.91 |
0.78 |
4.69 |
7% |
0.27 |
4.18 |
0.84 |
5.02 |
20% |
0.78 |
4.96 |
0.99 |
5.95 |
|
КЦРР-1205/13.08.2012 г |
28.12.2012 |
28.12.2012 |
Неактивен |
3635 |
| Somatostatin |
II-0860/15.10.2007 |
Somatostatin-UCB, Powder and solvent for solution for infusion, 3, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA, Belgium |
89.58 |
17.92 |
107.5 |
4% |
3.58 |
93.16 |
18.63 |
111.79 |
16% |
14.33 |
107.49 |
21.5 |
128.99 |
|
КЦ-673/06.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
1498 |
| Somatostatin |
II-0859/15.10.2007 |
Somatostatin-UCB, Powder and solvent for solution for infusion, 0.25, mg, Pack: 1 |
UCB Pharma SA, Белгия |
UCB Pharma SA, Belgium |
18.66 |
3.73 |
22.39 |
6% |
1.12 |
19.78 |
3.96 |
23.74 |
18% |
3.36 |
23.14 |
4.63 |
27.77 |
|
КЦ-673/06.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
3635 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Europe MA EEIG, Белгия |
Pfizer Manufacturing Belgium NV, Belgium |
3238.78 |
647.76 |
3886.54 |
4% |
10 |
3248.78 |
649.76 |
3898.54 |
16% |
25 |
3273.78 |
654.76 |
3928.54 |
Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 |
НСР-8981/14.04.2016.; НСР-17510/13.12.2018 |
28.12.2018 |
02.01.2019 |
Активен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Europe MA EEIG, Белгия |
Pfizer Manufacturing Belgium NV, Belgium |
3251.12 |
650.22 |
3901.34 |
4% |
10 |
3261.12 |
652.22 |
3913.34 |
16% |
25 |
3286.12 |
657.22 |
3943.34 |
Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 |
НСР-8981/14.04.2016. |
30.04.2016 |
02.12.2018 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3251.12 |
650.22 |
3901.34 |
4% |
10 |
3261.12 |
652.22 |
3913.34 |
16% |
25 |
3286.12 |
657.22 |
3943.34 |
Протокол №242/14.09.2017 |
НСР-8981/14.04.2016. |
30.04.2016 |
02.10.2017 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Europe MA EEIG, Белгия |
Pfizer Manufacturing Belgium NV, Belgium |
4834.36 |
966.87 |
5801.23 |
4% |
10 |
4844.36 |
968.87 |
5813.23 |
16% |
25 |
4869.36 |
973.87 |
5843.23 |
Протокол №242/14.09.2017; Промяна на обстоятелствата НСР-17199/09.11.2018 |
НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение |
25.06.2018 |
02.12.2018 |
Активен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
4834.36 |
966.87 |
5801.23 |
4% |
10 |
4844.36 |
968.87 |
5813.23 |
16% |
25 |
4869.36 |
973.87 |
5843.23 |
Протокол №242/14.09.2017 |
НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение |
25.06.2018 |
02.08.2018 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
4834.36 |
966.87 |
5801.23 |
4% |
10 |
4844.36 |
968.87 |
5813.23 |
16% |
25 |
4869.36 |
973.87 |
5843.23 |
Протокол №242/14.09.2017 |
НСР-8982/14.04.2016.; НСР-16011/25.06.2018 с предварително изпълнение* |
25.06.2018 |
02.07.2018 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 30 vials + 30 pre -filled syringes |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
4880.58 |
976.12 |
5856.7 |
4% |
10 |
4890.58 |
978.12 |
5868.7 |
16% |
25 |
4915.58 |
983.12 |
5898.7 |
Протокол №242/14.09.2017 |
НСР-8982/14.04.2016. |
30.04.2016 |
02.10.2017 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/003 |
Somavert, Powder for solution for injection, 20, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
6919.96 |
1383.99 |
8303.95 |
4% |
10 |
6929.96 |
1385.99 |
8315.95 |
16% |
25 |
6954.96 |
1390.99 |
8345.95 |
цената се заличава КЦРР-2538/14.03.2013 |
КЦ-3163/04.11.2011 |
06.03.2013 |
06.03.2013 |
Заличен |
1643 |
| Pegvisomant |
EU/1/02/240/003 |
Somavert, Powder for solution for injection, 20, mg, Pack: 30 |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
7132.23 |
1426.45 |
8558.68 |
4% |
10 |
7142.23 |
1428.45 |
8570.68 |
16% |
25 |
7167.23 |
1433.45 |
8600.68 |
изготвено корекционно решение КЦ-670/06.03.2009 |
КЦ-575/23.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
1643 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
4880.58 |
976.12 |
5856.7 |
4% |
10 |
4890.58 |
978.12 |
5868.7 |
16% |
25 |
4915.58 |
983.12 |
5898.7 |
|
НСР-8982/14.04.2016. |
30.04.2016 |
30.04.2016 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
4902.09 |
980.42 |
5882.51 |
4% |
10 |
4912.09 |
982.42 |
5894.51 |
16% |
25 |
4937.09 |
987.42 |
5924.51 |
Прот. № 136/16.09.2015 |
НСР-6850/30.07.2015 |
14.08.2015 |
14.08.2015 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
5062.69 |
1012.54 |
6075.23 |
4% |
10 |
5072.69 |
1014.54 |
6087.23 |
16% |
25 |
5097.69 |
1019.54 |
6117.23 |
|
НСР-4867/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
5121.16 |
1024.23 |
6145.39 |
4% |
10 |
5131.16 |
1026.23 |
6157.39 |
16% |
25 |
5156.16 |
1031.23 |
6187.39 |
|
НСР-2338/13.01.2014 |
28.01.2014 |
28.01.2014 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
5265.64 |
1053.13 |
6318.77 |
4% |
10 |
5275.64 |
1055.13 |
6330.77 |
16% |
25 |
5300.64 |
1060.13 |
6360.77 |
|
КЦ-3163/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/002 |
Somavert, Powder and solvent for solution for injection, 15, mg, Pack: 15 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
5349.2 |
1069.84 |
6419.04 |
4% |
10 |
5359.2 |
1071.84 |
6431.04 |
16% |
25 |
5384.2 |
1076.84 |
6461.04 |
|
КЦ-575/23.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
3301 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3251.12 |
650.22 |
3901.34 |
4% |
10 |
3261.12 |
652.22 |
3913.34 |
16% |
25 |
3286.12 |
657.22 |
3943.34 |
|
НСР-8981/14.04.2016. |
30.04.2016 |
30.04.2016 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3266.02 |
653.2 |
3919.22 |
4% |
10 |
3276.02 |
655.2 |
3931.22 |
16% |
25 |
3301.02 |
660.2 |
3961.22 |
Прот. № 136/16.09.2015 |
НСР-6849/30.07.2015 |
14.08.2015 |
14.08.2015 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3383.76 |
676.75 |
4060.51 |
4% |
10 |
3393.76 |
678.75 |
4072.51 |
16% |
25 |
3418.76 |
683.75 |
4102.51 |
|
НСР-4868/17.10.2014 |
03.11.2014 |
03.11.2014 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3420.26 |
684.05 |
4104.31 |
4% |
10 |
3430.26 |
686.05 |
4116.31 |
16% |
25 |
3455.26 |
691.05 |
4146.31 |
|
НСР-2338/13.01.2014 |
28.01.2014 |
28.01.2014 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3459.98 |
692 |
4151.98 |
4% |
10 |
3469.98 |
694 |
4163.98 |
16% |
25 |
3494.98 |
699 |
4193.98 |
|
КЦ-3163/04.11.2011 |
06.03.2013 |
06.03.2013 |
Неактивен |
3300 |
| Pegvisomant |
EU/1/02/240/001 |
Somavert, Powder and solvent for solution for injection, 10, mg, Pack: 10 mg powder x 30 vials + 8 ml solvent x 30 vials |
Pfizer Limited, Обединено Кралство |
Pfizer Manufacturing Belgium NV, Belgium |
3566.1 |
713.22 |
4279.32 |
4% |
10 |
3576.1 |
715.22 |
4291.32 |
16% |
25 |
3601.1 |
720.22 |
4321.32 |
|
КЦ-575/23.02.2009 |
10.03.2009 |
10.03.2009 |
Неактивен |
3300 |